Department of Chemistry, Princeton University
Copernicus Science Centre
“Innovation: what does it mean?”
Faculty of Chemistry, Gdansk University
Institute of Physical Chemistry PAS
“Artificial intelligence – threat or opportunity?”
|Dr. Anna Fabijańska, Ph.D., D.Sc. (born in 1982) is an Associate Professor in computer science at the Institute of Applied Computer Science of the Lodz University of Technology, Poland where she is also holding the position of the Institute’s vice director for the development. She received her master of engineering degree (2006), doctoral degree (2007) and habilitation degree (2013) in computer science from the Faculty of Electrical, Electronic, Computer and Control Engineering of the Lodz University of Technology. She also gained her scientific experience abroad at the University of Kent (UK), Claude Bernard University Lyon 1 (France) and University of Clermont Auvergne (France).
Her scientific interests focus on digital image processing and analysis, machine vision and artificial intelligence (especially deep learning). In particular, they concern the development of the dedicated image processing pipelines for computer-aided diagnosis systems and applications of computer vision in various fields of science and industry. She has authored/co-authored over 100 scientific papers which have been cited over 700 times.
She was a beneficiary of the Ministry of Science and Higher Education fellowship for outstanding young scientists in the years 2013-2015, a beneficiary of the Foundation for Polish Science (FNP) START fellowship in 2011 and the leader of scientific grants including the project within the framework of the Iuventus Plus programme in the years 2013-2015. Since 2016 she has been the member of The Polish Young Academy of the Polish Academy of Sciences and the member of the Committee on Informatics of the Polish Academy of Sciences. She has also served as an independent reviewer for the Polish National Science Center (NCN), The National Centre for Research and Development (NCBR) and the Netherlands Organisation for Scientific Research (NWO-WOTRO). Recently, she has been supervising 3 Ph.D. students in computer science.
Faculty of Electrical, Electronic, Computer and Control Engineering, Lodz University of Technology
Faculty of Chemical Technology, Poznan University of Technology
Information Technology (IT)
Poznan Supercomputing and Networking Center
|Katarzyna Starowicz-Bubak (PhD) is a neuropharmacologist leading a research group based at the Institute of Pharmacology Polish Academy of Sciences (www.if-pan.krakow.pl).
Her education includes M.Sc. degree in Biotechnology from the Jagiellonian University (2000), PhD in Pharmacology at the Medical Sciences at the Utrecht University (2005) and Habilitation in Medical Biology at the Faculty of Medicine of the Jagiellonian University Medical College (2013). After receiving a PhD degree, she started a postdoctoral fellowship in Endocannabinoid Research Group under the supervision of prof. Vincenzo Di Marzo. After completing the postdoctoral fellowship, she returned to Poland where she has established and maintained a laboratory focused on understanding of the mechanisms of chronic pain and on the characteristics of endogenous system involved in the transmission of pain stimuli with particular attention to endocannabinoid system. Subsequently, her research interests expanded to include the issue of degenerative joint disease (particularly osteoarthritis, OA) and more recently towards reward and motivation in pain and pain relief.
Please visit http://www.painlab.pl for more details and full description of current research interests.
Instytut Farmakologii PAN
|Dr Wojciech Fendler was born in 1982 in Lodz. His research interests expanded during medical studies and culminated in the Primus inter Pares award for the best medical student in Poland. After finishing his medical internship (008) he devoted fully to his scientific pursuits working in Professor’s Mlynarski group on monogenic diabetes. Dr Fendler’s PhD thesis (2011) concerned neonatal diabetes caused by mutations of the proinsulin gene. Expanded, nationwide epidemiological study on the matter resulted in the assembly of the most numerous group of patients with monogenic diabetes worldwide, spurring several publications in top diabetological journals and allowing dr Fendler to obtain his habilitation degree in 2013.
After setting up his independent scientific group, through the actions of the Mentoring programme of the FNP dr Fendler started a collaboration with the Dana-Farber Cancer Institute in Boston and expanded on his interest in circulating microRNAs. This collaboration resulted in publications in several high ranking journals: Science Translational Medicine (2015, 2017), Nature Communications (2017) and eLife (2017).
Right now dr Fendler leads his own research group at the Department of Biostatistics and Translational Medicine funded by the FNP’s First TEAM programme “Predictive biomarkers of radiation toxicity (PBRTox)”.
During his scientific career he obtained several prestigious awards for young researchers including two START scholarships, Medtronic-ISPAD Young Investigator Award and the Wierzuchowski’s lecture-award of Diabetes Poland – the highest award for scientific merit granted by this society.
|Dipanjan Chowdhury, PhD, is an Associate Professor of Medicine at Harvard Medical School, and Chief of the Division of Radiation and Genomic Stability in the Department of Radiation Oncology at Dana-Farber Cancer Institute and Associate Member of Broad Institute of Harvard a MIT. He is the Brigham &Women’s Hospital Distinguished Chair in Radiation Oncology. He is also an Affiliate Faculty Member of the Department of Biochemistry and Molecular Pharmacology and the Department of Immunology at Harvard Medical School. Dr. Chowdhury’s research focuses on deciphering cellular response to DNA damage, particularly DNA double strand breaks, with the goals of generating strategies for personalized radio and chemotherapy, and countering accidental radiation exposure. His work is supported by the NIH and several foundations, including the American Cancer Society, Ann-Fuller Foundation, Tina Brozman Foundation, Claudia Adams Barr program for Innovative Cancer Research and the Leukemia Lymphoma Society.
Dr. Chowdhury received his Bachelor of Science in Chemistry from St. Xavier’s College, Kolkata; his Master of Science in Biochemistry from Calcutta University, and his Doctor of Philosophy in Molecular Biology from Brandeis University.
Department of Radiation Oncology, Division of Radiation and Genome Stability, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Faculty of Chemistry, Adam Mickiewicz University in Poznań
Faculty of Chemistry, Gdańsk University of Technology
Big scientific facilities
Institute of Molecular Physics PAS